Eczema treated effectively with L-92 Patented Sterilized Lactic Acid Bacteria

Read Time:1 Minute, 18 Second

L-92 Patented Sterilized Lactic Acid Bacteria


A randomized, double-blind, placebo-controlled human intervention study included 49 AD patients ages 16 and older and found that changes in AD scores showed 70.8% of the subjects had an improvement in the L-92 group

A double-blind, placebo-controlled study was performed in children to determine if L-92 reduces symptoms of AD. L-92 given orally significantly reduced symptoms of AD in the children (see Chart 1 for symptom-medication scores during and after administration). L-92 also influenced thymus and activation-regulated chemokine in a time-dependent manner

Lactobacillus acidophilus strain L-92 (L-92) has potent immunomodulatory effects for different health conditions that have immune-mediated causes. It improves allergic conditions of the skin and respiratory tract by supporting normal histamine response to pollen (cedar pollen allergy), promoting normal breathing and seasonal nasal health in perennial allergic rhinitis, and helping support a normal skin immune and inflammatory response in atopic dermatitis (AD).

“believed to help balance cytokine levels.* Specifically, it may help tip the balance from excitatory to inhibitory cytokines by lowering levels of immunoglobin E in the blood, thus modulating the ratio between T-helper type 1 cells and T-helper type 2 cells.*”

Researched for:
Balancing the Immune System
Respiratory and Skin Health Effects
Nasal Allergies
Antiviral Effects in regards to H1N1 influenza virus
Incredible Safety Profile

Please like us on to stay current or for our archive.

Categories: Missed - Medical Breakthroughs

Average Rating

5 Star
4 Star
3 Star
2 Star
1 Star
%d bloggers like this: